The clinical manifestations of coagulopathy in cancer patients can vary widely. Patients may present with deep vein thrombosis (DVT), pulmonary embolism, or disseminated intravascular coagulation (DIC). Conversely, they may also experience bleeding complications such as hemorrhage, bruising, and petechiae. The presentation often depends on the balance between procoagulant and anticoagulant factors in the patient’s body.
